PPARD and pancreatic neoplasm: Our results show that PPARβ/δ activation by GW501516 suppresses expression of MMP-9 in human pancreatic cancer cells via BCL-6, with further inhibition on the ability of two cell lines, Miapaca-2 and BxPc-3, to invade a basement membrane.